Given the inhibitory activity of compound 23 and the antinociceptive effects of TRPM8 antagonists described in models of oxaliplatin (OXP)‐induced neuropathy [47, 48, 49], we conducted a behavioral experiment in mice to assess the antinociceptive effects of compound 23 after repeated oxaliplatin administration. The gene discussed is TRPM8; the disease is neuropathy.